Guest guest Posted June 7, 2002 Report Share Posted June 7, 2002 MDA update from a letter I received from Schenkenberger, Director of Administration, MDA Research Dept. in Tucson ~ FYI > > The Association’s present 3-year commitment for support of CMT > research is over $2 million. Much of the research has been directed at > identifying the underlying gene defects that result in the various > forms of CMT. Knowing the gene defects is a significant step toward > developing effective therapies. > > Researchers are now studying the biochemical and cellular processes in > CMT to identify the mechanism that causes the loss of nerves. This > will facilitate the development of therapies. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.